Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Paolo Giovanni Casali

Showing results (1-10 of 64) with videos related to

Pageof 7
Sort By:
Current Oncology Reports|May 18, 2011
Systemic therapy options for unresectable and metastatic chordomasSilvia Stacchiotti, Paolo Giovanni Casali
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|December 9, 2015
Adjuvant Imatinib for GI Stromal Tumors: When and For How Long?Robert S Benjamin, Paolo Giovanni Casali
Expert Review of Anticancer Therapy|November 22, 2007
Combined modalities approach for localized adult extremity soft-tissue sarcomaAlessandro Gronchi, Patrizia Olmi, Paolo Giovanni Casali
Medicine, Health Care, and Philosophy|November 21, 2020
Evaluating the effectiveness of clinical ethics committees: a systematic reviewChiara Crico, Virginia Sanchini, Paolo Giovanni Casali, et al.
Current Opinion in Oncology|May 10, 2024
New targeted therapies in liposarcoma: state of art and future perspectivesAndrea Franza, Chiara Fabbroni, Sandro Pasquali, et al.
Frontiers in Oncology|February 1, 2024
Long-term disease stability with bicalutamide in a man with aggressive angiomyxoma: case report and state of artAndrea Franza, Eleonora Gusmaroli, Chiara Fabbroni, et al.
Studies in Health Technology and Informatics|August 12, 2015
Understanding Deviations from Clinical Practice Guidelines in Adult Soft Tissue SarcomaEsther Goldbraich, Zeev Waks, Ariel Farkash, et al.
Annals of Surgery|April 17, 2007
Surgery of residual disease following molecular-targeted therapy with imatinib mesylate in advanced/metastatic GISTAlessandro Gronchi, Marco Fiore, Francesca Miselli, et al.
Annals of Surgery|February 5, 2010
Extremity soft tissue sarcoma in a series of patients treated at a single institution: local control directly impacts survivalAlessandro Gronchi, Salvatore Lo Vullo, Chiara Colombo, et al.
Tumori|June 16, 2026
End-of-life care: A retrospective study comparing sarcoma and patients with carcinomaLuca Zambelli, Giacomo Massa, Francesca Ricchini, et al.
Pageof 7

Showing results (1-10 of 64) with videos related to

Sort By:
Pageof 7
Current Oncology Reports|May 18, 2011
Systemic therapy options for unresectable and metastatic chordomasSilvia Stacchiotti, Paolo Giovanni Casali
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|December 9, 2015
Adjuvant Imatinib for GI Stromal Tumors: When and For How Long?Robert S Benjamin, Paolo Giovanni Casali
Expert Review of Anticancer Therapy|November 22, 2007
Combined modalities approach for localized adult extremity soft-tissue sarcomaAlessandro Gronchi, Patrizia Olmi, Paolo Giovanni Casali
Medicine, Health Care, and Philosophy|November 21, 2020
Evaluating the effectiveness of clinical ethics committees: a systematic reviewChiara Crico, Virginia Sanchini, Paolo Giovanni Casali, et al.
Current Opinion in Oncology|May 10, 2024
New targeted therapies in liposarcoma: state of art and future perspectivesAndrea Franza, Chiara Fabbroni, Sandro Pasquali, et al.
Frontiers in Oncology|February 1, 2024
Long-term disease stability with bicalutamide in a man with aggressive angiomyxoma: case report and state of artAndrea Franza, Eleonora Gusmaroli, Chiara Fabbroni, et al.
Studies in Health Technology and Informatics|August 12, 2015
Understanding Deviations from Clinical Practice Guidelines in Adult Soft Tissue SarcomaEsther Goldbraich, Zeev Waks, Ariel Farkash, et al.
Annals of Surgery|April 17, 2007
Surgery of residual disease following molecular-targeted therapy with imatinib mesylate in advanced/metastatic GISTAlessandro Gronchi, Marco Fiore, Francesca Miselli, et al.
Annals of Surgery|February 5, 2010
Extremity soft tissue sarcoma in a series of patients treated at a single institution: local control directly impacts survivalAlessandro Gronchi, Salvatore Lo Vullo, Chiara Colombo, et al.
Tumori|June 16, 2026
End-of-life care: A retrospective study comparing sarcoma and patients with carcinomaLuca Zambelli, Giacomo Massa, Francesca Ricchini, et al.
Pageof 7